Bactericidal and non‐cytotoxic activity of bacteriocin produced by <i>Lacticaseibacillus paracasei</i> <scp>F9</scp> ‐02 and evaluation of its tolerance to various physico‐chemical conditions-Reference-Cited by-同舟云学术

Bactericidal and non‐cytotoxic activity of bacteriocin produced by Lacticaseibacillus paracasei F9 ‐02 and evaluation of its tolerance to various physico‐chemical conditions

Published:2023-01-11 Issue: Volume: Page:
ISSN:1462-2912
Container-title:Environmental Microbiology
language:en
Short-container-title:Environmental Microbiology

Author:

Duraisamy Senbagam¹,Sathyan Aswathy¹,Balakrishnan Senthilkumar²,Subramani Prabhu³,Prahalathan Chidhambaram³,Kumarasamy Anbarasu¹^ORCID

Affiliation:

1. Microbial Biotechnology Laboratory, Department of Marine Biotechnology Bharathidasan University Tiruchirappalli Tamil Nadu India

2. Division of Biological Sciences, Tamil Nadu State Council for Science and Technology Chennai Tamil Nadu India

3. Department of Biochemistry Bharathidasan University Tiruchirappalli Tamil Nadu India

Funder

Tamil Nadu State Council for Higher Education

Council for Higher Education

Publisher

Wiley

Subject

Ecology, Evolution, Behavior and Systematics,Microbiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1462-2920.16327

Reference52 articles.

1. Antimicrobial Activity of a Bacteriocin Produced by Enterococcus faecalis KT11 against Some Pathogens and Antibiotic-Resistant Bacteria

2. Plantaricin bacteriocins: As safe alternative antimicrobial peptides in food preservation—A review

3. Inhibitory mechanism of BAC-IB17 against β-lactamase mediated resistance in methicillin-resistant Staphylococcus aureus and application as an oncolytic agent

4. Antimicrobial Peptides: Mechanisms of Action and Resistance

5. Characterization and purification of a bacteriocin from Lactobacillus paracasei subsp. paracasei BMK2005, an intestinal isolate active against multidrug-resistant pathogens

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glycine‐replaced epinecidin‐1 variant bestows better stability and stronger antimicrobial activity against a range of nosocomial pathogenic bacteria;Biotechnology and Applied Biochemistry;2024-07-21

2. Enterocin DD14 can inhibit the infection of eukaryotic cells with enveloped viruses;Archives of Microbiology;2024-05-20